Comprehensive morphological characterization of arthritis in animal models by microCT - innovative biomarkers for assessment of arthritic cartilage and bone.

Schrift Standard Fett
Login

Forschungsstelle

INNOSUISSE

Projektnummer

9853.1;16 PFLS-LS

Projekttitel

Comprehensive morphological characterization of arthritis in animal models by microCT - innovative biomarkers for assessment of arthritic cartilage and bone.

Projekttitel Englisch

Comprehensive morphological characterization of arthritis in animal models by microCT - innovative biomarkers for assessment of arthritic cartilage and bone.

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung	-	-	-
Abstract	-	-	-

Erfasste Texte

Kategorie	Text
Kurzbeschreibung (Englisch)	Comprehensive morphological characterization of arthritis in animal models by microCT - innovative biomarkers for assessment of arthritic cartilage and bone.
Abstract (Englisch)	The project will develop a quantitative imaging methodology (QIM) for morphological analysis of arthritic joints. The QIM will be commercialised for use in preclinical programs of pharmaceutical drug and medical device development. The validated protocols for imaging and analysing bone and cartilage tissues by microCT will provide substantially more quantitative information directly relevant to the development of treatments for arthritis and cartilage defects in a shorter time than is currently possible.

Kategorie

Text

Kurzbeschreibung
(Englisch)

Comprehensive morphological characterization of arthritis in animal models by microCT - innovative biomarkers for assessment of arthritic cartilage and bone.

Abstract
(Englisch)

The project will develop a quantitative imaging methodology (QIM) for morphological analysis of arthritic joints. The QIM will be commercialised for use in preclinical programs of pharmaceutical drug and medical device development. The validated protocols for imaging and analysing bone and cartilage tissues by microCT will provide substantially more quantitative information directly relevant to the development of treatments for arthritis and cartilage defects in a shorter time than is currently possible.